v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities      
Net loss $ (5,048,167) $ (7,137,375) $ (2,091,884)
Adjustments to reconcile net loss to net cash used in operating activities:      
Amortization of original issue discount   699,354
Depreciation expense 1,674 2,232
Realized loss on equity investment (50,760) (54,760)
Gain on extinguishment of liabilities (18,301)
Equity-based compensation 190,359 190,359 3,251
Inventory write-downs 154,483
Changes in operating assets and liabilities:      
Accounts receivable   28,801 134,588
Inventories   27,954 81,939
Prepaid expenses and other   (270,985) 20,026
Interest receivable   (41,293)
Accounts payable   2,115,073 603,489
Accrued compensation   337,690
Settlement payable   156,405
Accrued creator commissions   25,195
Accrued expenses   (300,312) 147,685
Accrued sales tax   (32,382)
Deferred revenue   370,064 (139)
Net cash used in operating activities   (3,902,281) (946,562)
Cash flows from investing activities      
Cash acquired through acquisition (Note 2)   591,686
Issuance of note receivable   (900,000)
Net cash used in investing activities   (308,314)
CASH FLOWS FROM FINANCING ACTIVITIES      
Proceeds from notes payable net of issuance costs   2,488,241 15,000
Proceeds from financing arrangement net of issuance cost   714,754
Proceeds from convertible notes payable   264,881
Proceeds from issuance of Series B preferred stock - net of issuance costs   805,017
Proceeds from issuance of Series C preferred stock - net of issuance costs   785,067
Net cash provided by financing activities   4,365,631 805,017
Net change in cash and restricted cash   155,036 (141,545)
Cash and restricted cash at beginning of period   155,647 336,340
Cash and restricted cash at end of period 310,683 310,683 194,795
Supplemental disclosure of cash flow information:      
Acquisition through issuance of Series D and Merger Warrants   75,000,000
Repayment of debt with investment   521,260
Forgiveness of note receivable and interest with note payable and interest from Acquisition   4,478,181
Warrants issued in conjunction with debt 213,553 213,553
Issuance cost in conjunction with name change 56,667 56,667
Accrued Series A dividends $ 53,433 $ 109,533 $ 56,133